GlassScriptPhysician profile
John C Kaczmarek
NPI 1134169204
$1,015.93
in general payments reported to CMS, 2019-2025
21 companies · $60.84 in 2025
The $60.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $51.16 · 2021: $82.59 · 2022: $241 · 2023: $87.59 · 2024: $217 · 2025: $60.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.34 | 2022-2024 | Wegovy |
| Astellas Pharma US INC | $117.98 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $115.30 | 2019 | |
| Pfizer INC. | $91.00 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $85.94 | 2023-2025 | |
| Exeltis, USA INC. | $63.11 | 2019-2024 | Slynd |
| Coopersurgical, INC. | $52.30 | 2019-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $48.58 | 2019-2021 | |
| Amgen INC. | $48.18 | 2021-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $34.57 | 2024 | Myfembree |
| Medtronic Vascular, INC. | $27.06 | 2019 | |
| Covidien LP | $22.92 | 2019 | |
| Organon LLC | $19.23 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.50 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.34 | 2019 | |
| Avanos Medical | $16.31 | 2019 | |
| Sage Therapeutics, LLC | $15.78 | 2024 | |
| Boston Scientific Corporation | $14.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kaczmarek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.